Short Bowel Syndrome: Clinical Trials

159 trials for Short Bowel Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

90 completed, 16 recruiting, 14 terminated, 12 unknown. 39 Not applicable, 35 Phase 3, 26 Phase 2, 13 Phase 4, 11 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable39Completed 18, Recruiting 6, Terminated 5, Unknown 5, Enrolling by invitation 2, Withdrawn 2, Not yet recruiting 1
Phase 335Completed 25, Active not recruiting 4, Recruiting 2, Terminated 2, Withdrawn 2
Phase 226Completed 10, Terminated 5, Withdrawn 4, Recruiting 3, Unknown 3, Not yet recruiting 1
Phase 413Completed 7, Terminated 3, Withdrawn 2, Recruiting 1
Phase 111Completed 7, Unknown 2, Terminated 1, Withdrawn 1
Early Phase 12Active not recruiting 1, Completed 1

Follow Short Bowel Syndrome: new trials by email Literature Review of Short Bowel Syndrome trials Research Report on Short Bowel Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of TRA16 Administered Orally in Patients With Enteric Hyperoxaluria (EH).
TRA16, Placebo - Enteric Hyperoxaluria
Phase 2Not yet recruitingWuhan Kangfude Urolithiasis Research Institute Co., Ltd.302027-03-012026-10-13
A Clinical Study of FT1 in Patients With Short Bowel Syndrome
FT1, Placebo - Short Bowel Syndrome, SBS
Phase 2RecruitingChongqing Peg-Bio Biopharm Co., Ltd.82026-08-302026-07-15
A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)
Apraglutide, Placebo - Short Bowel Syndrome (SBS), SBS Associated With Intestinal Failure (SBS-IF)
Phase 3RecruitingVectivBio AG1242026-08-012026-08-04
AGE Accumulation in Patients on Long-term Parenteral Nutrition
Non-invasive skin AGE measurements - Chronic Intestinal Insufficiency, Advanced Glycation and Products
Not applicableRecruitingUniversity Hospital, Bordeaux502026-07-222026-07-24
Role of the Microbiota in Intestinal Adaptation During Short Bowel Syndrome
collection of blood and stool/chyme and intestinal biopsy - Short Bowel Syndrome (SBS)
Not applicableNot yet recruitingAssistance Publique - Hôpitaux de Paris152026-04-012026-04-15
A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome
No Intervention - Short Bowel Syndrome (SBS)
RecruitingTakeda122026-03-052026-03-13
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
Glepaglutide, Placebo - Short Bowel Syndrome
Phase 3RecruitingZealand Pharma902026-02-112026-09-29
Effect of Parenteral Support on FibroScan in Short Bowel Syndrome
Fibroscan - Short Bowel Syndrome, Intestinal Failure
Not yet recruitingCopenhagen University Hospital, Rigshospitalet202026-02-012025-10-03
Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.
GLP-1 Receptor Agonists - Short Bowel Syndrome (SBS), Intestinal Failure
Not applicableCompletedJinling Hospital, China202026-01-242026-07-14
Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome
Glepaglutide 10 mg - Short Bowel Syndrome (SBS)
Phase 3Active not recruitingZealand Pharma282025-12-112026-07-30
Palliative Care Needs of Children With Rare Diseases and Their Families
Family Centered pediatric palliative care for family caregivers of children with rare diseases. - Trisomy 13 Syndrome, Arthrogryposis Congenita Multiplex With Intestinal Atresia
Not applicableEnrolling by invitationChildren's National Research Institute4802025-10-022026-01-28
Resting Energy Expenditure by Gastrointestinal Functional Status
Protocol-Defined Metabolic and Body Composition Assessment - Intestinal Failure, Short Bowel Syndrome
Not applicableRecruitingInstitute of Oncology Ljubljana922025-10-012026-07-20
A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome
Teduglutide - Short Bowel Syndrome
Phase 3Active not recruitingTakeda132025-06-262026-09-08
Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)
Crofelemer Powder for Oral Solution, Matched Placebo Powder for Oral Solution - Short Bowel Syndrome, Malabsorption Syndromes
Phase 2RecruitingNapo Therapeutics, S.p.A.182025-05-292026-06-09
Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome
Crofelemer Oral Product - Short Bowel Syndrome
Early Phase 1Active not recruitingJessica Sosio62025-03-032026-08-19
Specific Dietary Fibers May Enhance Colonic Adaptation in Short Bowel Syndrome Through Microbial and Metabolic Mechanisms That Drive Functional Compensation.
Dietary fiber intervention - Short Bowel Syndrome
Not applicableCompletedJinling Hospital, China102025-02-052025-09-22
SBS DISK- Creation of a Quality of Life Tool for Short Bowel Patients Compared With a Validated Quality of Life Questionnaire (SBS QoL)
Short Bowel Syndrome
RecruitingHospices Civils de Lyon1002025-01-152026-02-12
TED_ORG: Study on Short Bowel Syndrome
Teduglutide (ALX-0600), No Treatment Added - Short Bowel Syndrome (SBS)
Not applicableRecruitingMeyer Children's Hospital IRCCS502024-10-302026-11-18
Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition
PJ009, PJ009 Placebo - Short Bowel Syndrome
Phase 3Active not recruitingChongqing Peg-Bio Biopharm Co., Ltd.722024-09-032026-10-22
Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome
rhGH injection - Short Bowel Syndrome (SBS) in Adults
Phase 4RecruitingChangchun GeneScience Pharmaceutical Co., Ltd.1002024-07-312026-07-08

Showing 20 of 159. Sign in to see all of them.

Narrower conditions

Hyperphagia (24)  ·  Intestinal Failure (22)  ·  Cholestasis (11)  ·  Malabsorption Syndromes (10)  ·  Malnutrition (5)  ·  Enterocolitis, Necrotizing (4)  ·  Gastrointestinal Diseases (4)  ·  Crohn Disease (3)  ·  Digestive System Diseases (3)  ·  Gastroschisis (3)  ·  Intestinal Atresia (3)  ·  Intestinal Pseudo-Obstruction (3)  ·  Liver Diseases (3)  ·  Postoperative Complications (3)

Broader conditions

Pathological Conditions, Signs and Symptoms (158)  ·  Intestinal Diseases (157)  ·  Pathologic Processes (157)  ·  Digestive System Diseases (156)  ·  Postoperative Complications (156)  ·  Gastrointestinal Diseases (155)  ·  Malabsorption Syndromes (149)  ·  Signs and Symptoms (28)  ·  Signs and Symptoms, Digestive (25)  ·  Nutritional and Metabolic Diseases (19)  ·  Metabolic Diseases (14)  ·  Biliary Tract Diseases (13)  ·  Bile Duct Diseases (12)  ·  Gastroenteritis (10)  ·  Pathological Conditions, Anatomical (10)

Interventions

teduglutide (25)  ·  ALX-0600 (9)  ·  fish oil triglycerides (8)  ·  Needles (4)  ·  Syringes (4)  ·  apraglutide (4)  ·  soybean oil, phospholipid emulsion (4)  ·  Fish Oils (3)  ·  Growth Hormone (3)  ·  Standard of Care (3)  ·  Ethanol (2)  ·  Glucagon-Like Peptide 2 (2)  ·  SMOFlipid (2)  ·  Safflower Oil (2)  ·  Surveys and Questionnaires (2)

Sponsors

Shire (15)  ·  Takeda (10)  ·  Boston Children's Hospital (9)  ·  Zealand Pharma (7)  ·  Jinling Hospital, China (5)  ·  Mayo Clinic (5)  ·  University of Nebraska (4)  ·  VectivBio AG (4)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  Central Hospital, Nancy, France (3)  ·  Children's Hospital of Philadelphia (3)  ·  Chongqing Peg-Bio Biopharm Co., Ltd. (3)  ·  Hospices Civils de Lyon (3)  ·  9 Meters Biopharma, Inc. (2)  ·  Baxter Healthcare Corporation (2)

Countries

United States (80)  ·  France (26)  ·  Denmark (22)  ·  United Kingdom (20)  ·  Germany (17)  ·  Belgium (16)  ·  Poland (15)  ·  Canada (14)  ·  China (12)  ·  Italy (11)  ·  Japan (10)  ·  Netherlands (8)  ·  Spain (7)  ·  Argentina (5)  ·  Brazil (4)

Top investigators

Tomasz Masior (5)  ·  Mark Puder, MD, PhD (2)  ·  Michael Camilleri, MD (2)  ·  Qing Yang, MD, PhD (2)  ·  Thomas R Ziegler, MD (2)  ·  Wenjing Zong, MD (2)  ·  Alastair Forbes (1)  ·  Alastair Forbes, Medicine (1)  ·  Alexandra Carey, MD (1)  ·  Amanda Fifi, MD (1)  ·  Amir M Khan, MD (1)

Results publications

PMID 37364133, PMID 20980771, PMID 21317170, PMID 23453547, PMID 24134154, PMID 27507402, PMID 27855998, PMID 37889619, PMID 38873891, PMID 41858082, PMID 11017846, PMID 12761723, PMID 15137001, PMID 15530127, PMID 1559306, PMID 16099790, PMID 1734846, PMID 18927210, PMID 19661785, PMID 20094812, PMID 20172013, PMID 20179637, PMID 20413553, PMID 21324480, PMID 21975668, PMID 2292168, PMID 22982184, PMID 23274148, PMID 23333663, PMID 23381820, PMID 23395169, PMID 23486247, PMID 23587733, PMID 23770843, PMID 24392360, PMID 24603562, PMID 24637596, PMID 24667978, PMID 24999016, PMID 25841540, PMID 25858884, PMID 25941569, PMID 26059898, PMID 26223941, PMID 26675764, PMID 26708682, PMID 26770121, PMID 2680869, PMID 26838529, PMID 27491548

NIH funding

2004 (2), 2016 (2), 2017 (2), 2008 (1), 2009 (1), 2018 (1), 2025 (1), R01DK055850 (1), R01EB015911 (1), R01HD117137 (1), R01NR015743 (1), R03DK067123 (1), R21DK088027 (1), R44DK127658 (1), UL1TR000135 (1)